baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AUD/HUF Spot/

02/10/2024 10:17:28	Chg. +0.8536	Volume	Bid10:17:28	Ask10:17:28	High	Low
248.3464HUF	+0.34%	25,362 Turnover: 6.29 mill.	248.3023Bid Size: 1	248.3905Ask Size: 1	248.6818	247.2305

GlobeNewswire 15/07 Immuron announces record Travelan® sales globally, Australia and USA

GlobeNewswire 20/06 Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potentia...

GlobeNewswire 10/04 Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and Hi...

GlobeNewswire 10/04 Immuron Travelan® sales continued strong growth

GlobeNewswire 18/01 Adial Announces Appointment of Tony Goodman as Chief Operating Officer

GlobeNewswire 25/10/2023 Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorde...

GlobeNewswire 22/02/2022 MediciNova Announces MN-166 (ibudilast) Identified as Promising Pharmacotherapy for Alcohol Use Diso...

GlobeNewswire 09/12/2021 BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcoho...

GlobeNewswire 26/10/2021 Soberlink and the National Council of Juvenile and Family Court Judges Create Judge's Bench Card to ...

GlobeNewswire 10/08/2021 Adial Pharmaceuticals Awarded U.S. and International Patents for the Treatment Of Alcohol and Opioid...

GlobeNewswire 22/06/2021 Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for G...

GlobeNewswire 21/06/2021 MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disord...

GlobeNewswire 14/10/2019 Immuron North American Q1 Sales Up 111% YoY

GlobeNewswire 15/02/2019 Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence a...

GlobeNewswire 17/01/2019 Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Boar...

GlobeNewswire 10/12/2018 Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at th...

GlobeNewswire 12/09/2018 Alcohol Use Disorder Drug Candidate from Adial Pharmaceuticals Shows Positive Stability Results

GlobeNewswire 27/08/2018 Leading Addiction Focused Company Adial Pharmaceuticals Comments on Lancet Article Reporting Alcoho...

GlobeNewswire 28/02/2017 Aud Click, Portable WiFi & Bluetooth Speaker with Amazon Alexa, will be Available this March in UK a...

GlobeNewswire 23/10/2009 AMENDMENT AUD$13.1M capital raising announcement

GlobeNewswire 23/10/2009 AUD$13.1M Capital Raising

GlobeNewswire 24/04/2009 AUD$4M Capital Raising

GlobeNewswire 11/06/2008 Share Purchase Plan Mailing to Shareholders

AUD/HUF Spot/

If you wish to receive reply to your feedback, please provide your email address.